Skip to main content

The Value of PSA, Free-to-total PSA Ratio and PSA Density in the Prediction of Pathologic Stage for Clinically Localized Prostate Cancer

International Urology and Nephrology volume 37, pages 511–514 (2005)Cite this article

Abstract

Objective: The ability of prostate-specific antigen (PSA), free/total PSA and PSA density to predict the pathologic stage in prostate cancer has not been clear yet. In this study, we evaluated the value of PSA subgroups in the prediction of pathologic stage after radical prostatectomy. Methods: A total of 42 subjects 55–78-years-old who underwent radical retropubic prostatectomy were included in the study. Preoperative PSA, free/total PSA and PSA density (PSAD) values were compared according to the pathologic stages of radical prostatectomy specimens. Receiver operating characteristics (ROC) curves were measured for each parameter. Results: The clinical stage that was estimated for all patients was between T1N0M0 and T2bN0M0. Pathologic examination revealed organ-confined disease in 18 patients. The area under curve (AUC) for organ confinement was 0.553 for PSA, 0.446 for free/total PSA ratio and 0.706 for PSAD. Cut-off values providing the best sensitivity and specificity in ROC analysis for PSA, free/total PSA and PSAD were 7.1, 0.15, and 0.17, respectively (likelihood ratio: 0.9, 1 and 2). The positive predictive values at these cut-off values were 0.54, 0.56, and 0.70, respectively. Only PSAD cut-off values was found statistically borderline significant for predicting organ-confined disease. Conclusion: While PSAD is more helpful than PSA and free/total PSA ratio for prediction of organ-confined disease, none of these parameters are significant predictor of pathologic stage for clinically localized prostate cancer.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. A Jemal T Murray A Samuels et al. (2003) ArticleTitleCancer statistics CA Cancer J Clin 53 5–26 Occurrence Handle12568441 Occurrence Handle10.3322/canjclin.53.1.5

    PubMed  Article  Google Scholar 

  2. AW Partin MW Kattan EN Subong et al. (1997) ArticleTitleCombination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update JAMA 277 1445–1451 Occurrence Handle10.1001/jama.277.18.1445 Occurrence Handle9145716 Occurrence Handle1:STN:280:ByiB1M7htVY%3D

    Article  PubMed  CAS  Google Scholar 

  3. JE Oesterling SJ Jacobsen CG Chute et al. (1993) ArticleTitleSerum prostate- specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges JAMA 270 860–864 Occurrence Handle10.1001/jama.270.7.860 Occurrence Handle7688054 Occurrence Handle1:STN:280:ByyA2c7gs1E%3D

    Article  PubMed  CAS  Google Scholar 

  4. V Ravery C Chastang M Toublanc et al. (2000) ArticleTitlePercentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1-T2 prostate cancer Eur Urol 37 449–455 Occurrence Handle10.1159/000020167 Occurrence Handle10765076 Occurrence Handle1:STN:280:DC%2BD3c3ivFKmtw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  5. J Pannek AW. Partin (1997) ArticleTitleProstate-specific antigen: what’s new in 1997 Oncology (Huntingt) 11 1273–1278 Occurrence Handle1:STN:280:ByiH2M7ks1A%3D

    CAS  Google Scholar 

  6. AA Elgamal FJ Cornillie HP Poppel ParticleVan et al. (1996) ArticleTitleFree-to-total prostate specific antigen ratio as a single test for detection of significant stage T1c prostate cancer J Urol 156 1042–1049 Occurrence Handle8709304 Occurrence Handle1:STN:280:BymA38%2Fps1E%3D

    PubMed  CAS  Google Scholar 

  7. J Noldus M Graefen E Huland et al. (1998) ArticleTitleThe value of the ratio of free-to-total prostate specific antigen for staging purposes in previously untreated prostate cancer J Urol 159 2004–2007 Occurrence Handle9598507 Occurrence Handle1:STN:280:DyaK1c3lvVCmtg%3D%3D

    PubMed  CAS  Google Scholar 

  8. AR Zlotta B Djavan M Petein et al. (1998) ArticleTitleProstate specific antigen density of the transition zone for predicting pathological stage of localized prostate cancer in patients with serum prostate specific antigen less than 10 ng/ml J Urol 160 2089–2095 Occurrence Handle9817330 Occurrence Handle1:STN:280:DyaK1M%2Fjt1ansA%3D%3D

    PubMed  CAS  Google Scholar 

  9. JW Catalona PC Southwick KM Slawin et al. (2000) ArticleTitleComparison of percent free PSA, PSA Density, and age-specific PSA cut-offs for prostate cancer detection and staging Urology 56 255–260 Occurrence Handle10.1016/S0090-4295(00)00637-3 Occurrence Handle10925089 Occurrence Handle1:STN:280:DC%2BD3czpsVarsA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  10. B Tombal M Querton P Nayer ParticleDe et al. (2002) ArticleTitleFree/total PSA ratio does not improve prediction of pathologic stage and biochemical recurrence after radical prostatectomy Urology 59 256–260 Occurrence Handle10.1016/S0090-4295(01)01515-1 Occurrence Handle11834398

    Article  PubMed  Google Scholar 

  11. I Hara H Miyake S Hara et al. (2001) ArticleTitleValue of the serum prostate-specific antigen, α1-antichymotrypsin complex and its density as a predictor for the extent of prostate cancer BJU International 88 53–57 Occurrence Handle10.1046/j.1464-410x.2001.02238.x Occurrence Handle11446846 Occurrence Handle1:CAS:528:DC%2BD3MXntVSmu78%3D

    Article  PubMed  CAS  Google Scholar 

  12. AR Zlotta B Djavan M Marberger et al. (1997) ArticleTitleProstate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction J Urol 157 1315–1321 Occurrence Handle9120930 Occurrence Handle1:STN:280:ByiB38zhslI%3D

    PubMed  CAS  Google Scholar 

  13. Schroder FH, Hermanek P, Denis L et al. The TNM classification of prostate cancer. Prostate 1992; (suppl. 4): 129–138.

  14. F Cornud X Belin T Flam et al. (1996) ArticleTitleLocal staging of prostate cancer by endorectal MRI using fast spin-echo sequences: prospective correlation with pathological findings after radical prostatectomy Br J Urol 77 843–850 Occurrence Handle8705219 Occurrence Handle1:STN:280:BymA3svoslw%3D

    PubMed  CAS  Google Scholar 

  15. SA McSherry F Levy ML Schebler et al. (1991) ArticleTitlePreoperative prediction of pathological tumor volume and stage in clinically localized prostate cancer: comparison of digital rectal examination, transrectal ultrasonography and magnetic resonance imaging J Urol 146 85–89 Occurrence Handle1711590 Occurrence Handle1:STN:280:By6B2sfitFE%3D

    PubMed  CAS  Google Scholar 

  16. JA Smith SuffixJr PT Scardino MI Resnick et al. (1997) ArticleTitleTransrectal ultrasound versus digital examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial J Urol 157 902–906 Occurrence Handle9072596

    PubMed  Google Scholar 

  17. CH Bangma R Kranse BG Blijenberg et al. (1997) ArticleTitleThe free-to-total serum prostate specific antigen ratio for staging prostate carcinoma J Urol 157 544–547 Occurrence Handle8996352 Occurrence Handle1:STN:280:ByiC2cblsVA%3D

    PubMed  CAS  Google Scholar 

  18. J Morote G Encabo JM. deTorres (2000) ArticleTitleUse of percent free prostate-specific antigen as a predictor of the pathological features of clinically localized prostate cancer Eur Urol 38 225–229 Occurrence Handle10895016 Occurrence Handle1:STN:280:DC%2BD3cvjs1altg%3D%3D

    PubMed  CAS  Google Scholar 

  19. JI Epstein DW Chan LJ Sokoll et al. (1998) ArticleTitleNonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings J Urol 160 2407–2411 Occurrence Handle9817393 Occurrence Handle1:STN:280:DyaK1M%2Fjt1ejtw%3D%3D

    PubMed  CAS  Google Scholar 

  20. HB Carter J Sauvageot PC Walsh et al. (1997) ArticleTitleProspective evaluation of men with stage T1 C adenocarcinoma of the prostate J Urol 157 2206–2209 Occurrence Handle9146616 Occurrence Handle1:STN:280:ByiB1M3gslI%3D

    PubMed  CAS  Google Scholar 

  21. K Shinohara JS Wolf SuffixJr. P Narayan PR. Carroll (1994) ArticleTitleComparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications J Urol 152 120–123 Occurrence Handle7515447 Occurrence Handle1:STN:280:ByuB28%2Fls10%3D

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Urology and Pathology, School of Medicine, Dokuz Eylul University, Inciralti, Izmir, 35340, Turkey

    Güven Aslan, Bora İrer, Aykut Kefi, İlhan Çelebi, Kutsal Yörükoğlu & Adil Esen

Authors
  1. Güven Aslan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bora İrer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aykut Kefi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. İlhan Çelebi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kutsal Yörükoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Adil Esen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Güven Aslan.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Aslan, G., İrer, B., Kefi, A. et al. The Value of PSA, Free-to-total PSA Ratio and PSA Density in the Prediction of Pathologic Stage for Clinically Localized Prostate Cancer. Int Urol Nephrol 37, 511–514 (2005). https://doi.org/10.1007/s11255-005-0921-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-005-0921-x

Keywords

  • Prostate
  • Prostate cancer
  • PSA
  • PSAD
  • Staging